← Eichor
Study identifier: NCT07724990 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Specific Probiotic in thE MOdulation of Gut Microbiota of patieNts With Mild-to-modErate Ulcerative Colitis

Condition: Ulcerative Colitis · Crohn Disease  ·  Sponsor: Catholic University of the Sacred Heart

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Probiotics are live microorganisms that provide health benefits when consumed in sufficient amounts. Traditional probiotics, mainly from the Lactobacillus and Bifidobacterium genera, originate from fermented foods or the human gut and are widely used in supplements. Although considered safe and easy to produce, they are not specifically designed to treat diseases, and no official health claims have been approved by EFSA. Advances in microbiome research have led to the discovery of Next-Generation Probiotics (NGPs), which are newly identified gut microbes associated with health and offer promising therapeutic potential despite lacking a long history of safe use.

This description comes directly from the study's public registry record.

Talk to the study team

Antonio Gasbarrini  ·  0630157104  ·  antonio.gasbarrini@unicatt.it

Always discuss trial participation with your own doctor first.

Locations (1)

Fondazione Policlinico Universitario Agostino Gemelli, IRCCSRoma, RM, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07724990